Generated by GPT-5-mini| EMBO Long-Term Fellowships | |
|---|---|
| Name | EMBO Long-Term Fellowships |
| Established | 1964 |
| Awarding body | European Molecular Biology Organization |
| Location | Heidelberg |
EMBO Long-Term Fellowships The EMBO Long-Term Fellowships provide postdoctoral funding to support research mobility across the life sciences and related molecular biology fields. The program enables hosted training and cross-border exchange among laboratories in Europe and partner regions, fostering ties between institutions, funders, and research networks.
The program is administered by the European Molecular Biology Organization in coordination with institutions such as the European Molecular Biology Laboratory and national funding agencies like the Wellcome Trust, Medical Research Council (United Kingdom), and Agence Nationale de la Recherche. Historically linked to initiatives at CERN and collaborations with universities such as University of Cambridge, University of Oxford, Heidelberg University, Karolinska Institutet, and Université Paris-Saclay, the fellowships aim to accelerate careers similar to pathways supported by awards such as the Marie Skłodowska-Curie Actions and the Human Frontier Science Program. Prominent research areas mirror work at centers like the Max Planck Society, Cold Spring Harbor Laboratory, Sanger Institute, Francis Crick Institute, and the Broad Institute.
Eligibility aligns with criteria used by funders such as the Alexander von Humboldt Foundation, EMBL Partnership, and national academies including the Royal Society and Académie des sciences (France). Applicants are typically recent PhD holders who have worked at institutions like ETH Zurich, Imperial College London, University of Cambridge, University of Göttingen, or University of Zurich. Applicants prepare proposals referencing host laboratories such as those led by investigators at Max Delbrück Center for Molecular Medicine, Institut Pasteur, Weizmann Institute of Science, University of Edinburgh, or Karolinska Institutet. The application process requires letters from host group leaders affiliated with organizations including the European Research Council, Wellcome Sanger Institute, or national research councils such as the Deutscher Forschungsgemeinschaft and the National Institutes of Health for eligible partner-country placements.
Funding modalities reflect models used by the European Commission and grant programs like the ERC Starting Grant and the Horizon Europe framework, offering stipends, mobility allowances, and research costs analogous to awards from the Gates Foundation or Chan Zuckerberg Initiative when co-funding occurs. Typical durations match postdoctoral appointments at institutions such as Princeton University, Harvard University, Yale University, or Columbia University and are comparable to multi-year schemes from the National Science Foundation and the Swiss National Science Foundation.
Research topics span molecular biology subfields investigated at centers like the Sanger Institute, EMBL-EBI, Max Planck Institute for Developmental Biology, Cold Spring Harbor Laboratory, and Broad Institute. Projects often interface with platforms and consortia such as ENCODE Project, Human Cell Atlas, Cancer Research UK collaborations, and initiatives connected to the European Research Area. Mobility expectations encourage exchanges similar to rotations at laboratories within networks involving Karolinska Institutet, University of Cambridge, ETH Zurich, and partner institutions in the United States, Japan, and Australia.
Selection is competitive and peer-reviewed using panels that include members from organizations like the European Molecular Biology Organization, EMBL, Royal Society, EMBO Conference speakers, and reviewers affiliated with institutions such as the Max Planck Society, Institute Pasteur, and leading universities. Criteria emphasize scientific excellence comparable to standards at the Howard Hughes Medical Institute, novelty akin to projects funded by the Human Frontier Science Program, feasibility similar to ERC assessments, and the potential for career development parallel to benchmarks used by the Marie Skłodowska-Curie Actions. Reviewers consider publication records in journals such as Nature, Science, Cell, PNAS, and discipline-specific outlets.
Fellows undertake research under host supervisors from institutions like EMBL, Sanger Institute, Wellcome Trust Sanger Institute, Institut Pasteur, and university departments at University of Oxford, University of Cambridge, and UCL. Responsibilities include producing outputs measured by citation databases managed by entities such as Clarivate, participating in training events comparable to Gordon Research Conferences and EMBO Workshops, and adhering to mobility and reporting obligations observed in programs like Marie Skłodowska-Curie Actions. Benefits include networking opportunities with alumni linked to the European Molecular Biology Laboratory, career development support resembling services from the Royal Society and access to conferences at venues such as the EMBO Conference Centre.
Alumni have progressed to positions at institutions including the Max Planck Society, Harvard University, Stanford University, ETH Zurich, Karolinska Institutet, Francis Crick Institute, and leadership roles in biotech firms similar to those spun out from Cambridge Biomedical Campus projects. Career trajectories reflect transitions to faculty roles under schemes like the EMBO Young Investigator Programme and grants from the European Research Council or national academies such as the Royal Society and the Academy of Sciences in various countries. The fellowship's influence is visible in collaborations across consortia like the Human Genome Project-era networks, translational initiatives partnered with Cancer Research UK and technology transfers to industry clusters centered around Boston, Cambridge (UK), and Heidelberg.
Category:Grants and fellowships